Aminoindazole derivatives and use thereof as kinase inhibitors

Details for Australian Patent Application No. 2003278250 (hide)

Owner Aventis Pharma S.A.

Inventors Babin, Didier; Dutruc-Rosset, Gilles; Halley, Franck; Rooney, Thomas; Lesuisse, Dominique; Tiraboschi, Gilles

Agent Watermark

Pub. Number AU-B-2003278250

PCT Number PCT/FR03/02634

PCT Pub. Number WO2004/062662

Priority FR 02 15720 12.12.02 FR; 60/444,630 04.02.03 US

Filing date 3 September 2003

Wipo publication date 10 August 2004

Acceptance publication date 11 February 2010

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): FR 02 15720 12.12.02 FR; 60/444,630 04.02.03 US

9 September 2004 Application Open to Public Inspection

  Published as AU-B-2003278250

11 February 2010 Application Accepted

  Published as AU-B-2003278250

10 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278251-Posterior vertebral support assembly

2003278249-Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same